Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheuminations: Epigenetics May Help to Explain Why Some Get Rheumatic Disease

Simon M. Helfgott, MD  |  Issue: March 2013  |  March 1, 2013

That may have reassured some and angered others. However, I thought that I detected a subtle subtext. Several of the patients I met presented with engaging clinical issues that raised some interesting questions about the interplay between genes and environmental stresses. I thought I would share a few of their stories with you.

John: The Iron Man

As we acquire more knowledge, things do not become more comprehensible, but more mysterious.

—Albert Schweitzer

John, a middle-aged retired banker, drove to Boston from his home in coastal Rhode Island. A few years earlier, one of his severely damaged knees had been replaced at another Boston hospital. Decades earlier, John had been a college athlete; his squat body shape belied an impressive tennis career. Though his knee pain resolved after surgery, he noticed worsening joint pain elsewhere. He could no longer grip his tennis racket. His feet ached when he walked. At the age of 55, he reluctantly took an early retirement from his job.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

At first, I thought there was not much else that I could offer John for the management of his severe, generalized osteoarthritis. Facing John, I was reminded of the Osler quip about running out the back door when the patient with arthritis comes through the front door. (With all of 65 square feet of office space and one door, I have nowhere to run!) But when I studied John’s hands, I realized that the degree of soft-tissue swelling and bony enlargement present around his metacarpal–phalangeal joints was inconsistent with his previous diagnoses of rheumatoid arthritis (RA) or primary osteoarthritis. A couple of X-rays and a few blood tests later, a new opinion emerged: hemochromatosis.

What a cool diagnosis for a rheumatologist to make! Unlike the internist who diagnoses hemochromatosis based on the results of a screening serum iron test in an asymptomatic patient (sheer luck) or the endocrinologist who suspects it to be present in someone with “bronze diabetes” (that’s pretty late in the game), with a minimum of clues, we can identify those afflicted relatively early in their disease.

A puffy knuckle, an errant teardrop-shaped osteophyte, some calcified cartilage. These are all the clues we need to make the diagnosis. Although it may be too late to repair the already-damaged joints, we can forestall further articular devastation and prevent major organ damage while alerting family members about the errant gene that may be lurking in their midst. John’s serum ferritin level of 2,700 left little doubt about the diagnosis. Genetic testing confirmed that he was homozygous for the most common gene causing hemochromatosis, the HFE variant.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:OpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:epigeneticsResearchRheumatic Disease

Related Articles
    Kateryna Kon / Shutterstock.com

    How to Manage, Treat Anemia of Inflammation in Patients with Rheumatic Disease

    December 17, 2017

    Anemia is common in patients with systemic rheumatic disease, yet it may not get the attention it deserves. Anemia can result from chronic inflammation, treatment side effects or other disease factors, or it may signal an unrelated condition. Although diagnosis and treatment of anemia are sometimes challenging, clinicians must do their utmost to rigorously investigate…

    The Latest on Epigenetics in Immune-Mediated Disease

    March 19, 2019

    CHICAGO—Because the epigenome has been implicated in a variety of rheumatic conditions, a Basic Research Conference was convened on Epigenetics in Immune-Mediated Disease in conjunction with the 2018 ACR/ARHP Annual Meeting. Melanie Ehrlich, PhD, professor of human genetics and genomics at Tulane University School of Medicine, New Orleans, opened the conference. She has a long…

    A 52-Year-Old Lupus Paper Remains Important Today

    December 14, 2020

    Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythema­tosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…

    Drug Commercials—How Are They Still a Thing?

    July 19, 2018

    Picture this: It’s 3 o’clock in the morning. You can’t sleep. You settle in front of the television to watch a rerun of Dirty Dancing. And then it hits you: Ask your doctor. Even as your eyelids sag, some part of your primitive forebrain snaps to attention. Medical training has turned us all into multitaskers,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences